Grant: Strategic Projects - Group
University of Alberta
$148,500.00
Developing low-intensity pulsed ultrasound device for microorganism growth
FY 2008-09
Summary
Health care spending continues to grow faster than our economy and becomes a major financial burden to the society (Provincial and territorial government health spending surpassed $100 billion in 2007). Drugs have consumed the second-largest share of health dollars (second after Hospitals) since 1997. The fermentation process is commonly used in the pharmaceutical industry to grow microorganisms and produce drugs, like antibiotics. In this strategic research, the applicants propose to collaborate with researchers at Apotex Fermentation Inc. and Alberta Research Council to design low-intensity pulsed ultrasound (LIPUS) devices for microorganism growth. LIPUS is chosen because a form of mechanical energy generated by the LIPUS device can pass through into microorganism as acoustic pressure waves that can stimulate microorganism growth. Our piezoelectric transducers are biocompatible and are easily modified for fermentation use. The proposed research includes: (i) developing a novel LIPUS device that can stimulate microbial growth and enhance gene and protein expressions to increase fermentation-based drug yield; (ii) demonstrating that the proof-of-concept designs can be used in the fermentation processes to produce predictable microbial growth; (iii) extending this new technology for industrial applications. Our design is innovative because no research group worldwide has proposed to use LIPUS for enhancing microorganism growth.
NSERC has invested a great amount of money in fundamental research. The proposed research will enhance the collaboration between academia, government lab and industry. The proposed research is also in line with NSERC strategic research plans in the area of "Competitive Manufacturing and Value-Added Products and Processes". By applying LIPUS technology, the yield of fermentation-based drugs could improve significantly. As a result, the project can reduce health costs and enhance the ability of Canadian drugs to compete in global markets. In all, this project will significantly benefit the Canadian economy.
Program
Strategic Projects - Group
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
365241-2008
Name nom
Chen, Jie
Department département
Electrical and Computer Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
148500
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1044
Committee name en
Strategic Projects Selection Panel - Food and Bioproducts
Committee name fr
Comité de sélection des projets stratégiques - Aliments et bioproduits
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
3
Application title
Developing low-intensity pulsed ultrasound device for microorganism growth
Keyword
NA
Application summary
Health care spending continues to grow faster than our economy and becomes a major financial burden to the society (Provincial and territorial government health spending surpassed $100 billion in 2007). Drugs have consumed the second-largest share of health dollars (second after Hospitals) since 1997. The fermentation process is commonly used in the pharmaceutical industry to grow microorganisms and produce drugs, like antibiotics. In this strategic research, the applicants propose to collaborate with researchers at Apotex Fermentation Inc. and Alberta Research Council to design low-intensity pulsed ultrasound (LIPUS) devices for microorganism growth. LIPUS is chosen because a form of mechanical energy generated by the LIPUS device can pass through into microorganism as acoustic pressure waves that can stimulate microorganism growth. Our piezoelectric transducers are biocompatible and are easily modified for fermentation use. The proposed research includes: (i) developing a novel LIPUS device that can stimulate microbial growth and enhance gene and protein expressions to increase fermentation-based drug yield; (ii) demonstrating that the proof-of-concept designs can be used in the fermentation processes to produce predictable microbial growth; (iii) extending this new technology for industrial applications. Our design is innovative because no research group worldwide has proposed to use LIPUS for enhancing microorganism growth.
NSERC has invested a great amount of money in fundamental research. The proposed research will enhance the collaboration between academia, government lab and industry. The proposed research is also in line with NSERC strategic research plans in the area of "Competitive Manufacturing and Value-Added Products and Processes". By applying LIPUS technology, the yield of fermentation-based drugs could improve significantly. As a result, the project can reduce health costs and enhance the ability of Canadian drugs to compete in global markets. In all, this project will significantly benefit the Canadian economy.